2023 annual financial data
Arrowhead Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -85.16%.
Operating income was -205,002,000 USD and net income was -205,275,000 USD.
Operating cash flow was -153,890,000 USD.
Get free Arrowhead Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 240,735,000 USD
- Operating income
- -205,002,000 USD
- Net income
- -205,275,000 USD
- Operating cash flow
- -153,890,000 USD